|
Market Closed -
Nasdaq Stockholm
21:00:00 29/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.3755 SEK | +1.08% |
|
-10.38% | -54.70% |
| 10-21 | Alzinova Finalizes US Trial Sites for Mid-stage Alzheimer's Disease Vaccine Study | MT |
| 10-21 | Alzinova selects seven U.S. trial sites ahead of phase IIa study | FW |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ALZINOVA AB | Other Biotechnology & Medical Research | +1.08% | -10.38% | -54.70% | -76.29% | -94.99% | 11.84M |  | | |
- Stock Market
- Stocks
- ALZ Stock
- Charts Alzinova AB
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
